Status:
COMPLETED
Dermatopharmacokinetic Trial of LEO 90100 Foam
Lead Sponsor:
LEO Pharma
Conditions:
Healthy
Eligibility:
MALE
20-40 years
Phase:
PHASE1
Brief Summary
This is a phase 1, single centre trial in Japanese healthy male subjects comparing the amount of active ingredients of LEO 90100 foam and Dovobet® ointment in the stratum corneum.
Eligibility Criteria
Inclusion
- Healthy Japanese male subjects, aged 20 to 40 years inclusive
Exclusion
- Body Mass Index outside the range 18-25 kg/m²
- Use of any medication (systemic or topical) within 2 weeks of Day 1.
Key Trial Info
Start Date :
March 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT03476746
Start Date
March 20 2018
End Date
July 1 2018
Last Update
February 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigational site
Fukuoka, Japan, 812-0025